相关实验视频
Updated: Sep 18, 2025

06:40
The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
6.7K
使用日本药物不良事件报告数据库对食道的分析
Teruaki Hayashi1, Kazumasa Kotake2, Miyu Fujioka1
1School of Pharmacy, Hyogo Medical University.
Journal of clinical gastroenterology
|June 23, 2025
概括
这项研究使用日本不良药物事件报告 (JADER) 数据库确定了与食道相关的口服和肠外药物. 早期检测和干预对于治疗药物诱导的食道至关重要.
科学领域:
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
- 胃肠病学 胃肠病学
背景情况:
- 药物诱导的食道通常与口服药物有关.
- 新出现的证据表明,肠道药物也可能导致食道,但这些病例缺乏全面的分析.
- 这项研究解决了对对肠道药物相关食道的详细检查的需要.
研究的目的:
- 为了识别与食道相关的口服和肠外药物.
- 分析药物诱导的食道的发病模式.
- 支持食道的早期检测和预防策略.
主要方法:
- 日本药物不良事件报告 (JADER) 数据库的不成比例分析 (2004年4月 - 2023年12月).
- 使用报告几率比率 (ROR) 进行信号检测,以95%的置信区间.
- 韦布尔分布分析,以确定已识别药物的不良事件发生时间.
主要成果:
- 对于15种口服药物和7种肠道抗癌药物检测到食道的信号.
- 多西环素和达比加特兰乙酸盐显示药物诱导的食道炎的早期发病 (中位数为8天和12.5天).
- 在整个治疗过程中,贝瓦齐祖马布和帕克利塔克塞尔呈现出一致的食道.
结论:
- 综合分析确定了口服和亲肠道药物的食道信号.
- 在不同药物类别中观察到特征性的发病模式.
- 对特定的口服和肠道药物的临床警对于早期干预和预防食道是必不可少的.
相关概念视频
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
209
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
209
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
707
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
707
Pharmacovigilance
1.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.0K
Peptic Ulcer Disease IV: Management
150
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
150
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
574
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
574
Peptic Ulcer Disease I: Introduction
302
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
302

